Oritavancin Activity against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients, 2009-2010

Oritavancin exhibited potent activity against vancomycin-susceptible (MIC(50) and MIC(90), 0.015/0.03 μg/ml) and vanB-carrying E. faecalis isolates (MIC(50) and MIC(90), 0.015 and 0.015 μg/ml). Higher (16- to 32-fold) MIC(50)s and MIC(90)s for vanA-harboring E. faecalis were noted (MIC(50) and MIC(9...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mendes, Rodrigo E., Woosley, Leah N., Farrell, David J., Sader, Helio S., Jones, Ronald N.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2012
Onderwerpen:
Epidemiology and Surveillance
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294904/
https://ncbi.nlm.nih.gov/pubmed/22183169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06067-11
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items